RBC Capital analyst Natalia Webster raised the firm’s price target on Diaceutics (DIUXF) to 195 GBp from 165 GBp and keeps an Outperform rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DIUXF:
- Diaceutics Director Increases Stake Signaling Confidence in Company Growth
- Diaceutics Enhances Employee Incentive Program with Share Awards
- Diaceutics Reports Strong FY 2024 Growth and Positive Outlook
- Diaceutics Opens New US Headquarters to Boost Market Presence
- Diaceutics Unveils Pathology Engagement Service with $1.8m Contract